Ancho de distribución eritrocitaria como potencial biomarcador clínico en enfermedades cardiovasculares

Red cell distribution width (RDW) is a measurement of the variation in size, as well as an index of heterogeneity of erythrocytes, which is used in combination with other hematologic parameters as an aid to the differential diagnosis of hypochromic anemia. RDW could also serve as a biomarker in the...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Alcaíno,Hernán, Pozo,José, Pavez,Mario, Toledo,Humberto
Lenguaje:Spanish / Castilian
Publicado: Sociedad Médica de Santiago 2016
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872016000500012
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0034-98872016000500012
record_format dspace
spelling oai:scielo:S0034-988720160005000122016-08-31Ancho de distribución eritrocitaria como potencial biomarcador clínico en enfermedades cardiovascularesAlcaíno,HernánPozo,JoséPavez,MarioToledo,Humberto Biomarkers Cardiovascular Diseases Erythrocytes Prognosis Red cell distribution width (RDW) is a measurement of the variation in size, as well as an index of heterogeneity of erythrocytes, which is used in combination with other hematologic parameters as an aid to the differential diagnosis of hypochromic anemia. RDW could also serve as a biomarker in the diagnosis and prognosis patients with cardiovascular diseases. However, it is unclear whether the increased heterogeneity is the cause or consequence of other pathophysiological conditions such as renal failure, malnutrition, inflammation and oxidative stress, which among other conditions are actively involved in the genesis and progression of cardiovascular diseases. The aim of this review is to show and discuss recent evidence about the role of RDW measurement as an aid in the diagnosis and prognosis of patients with such diseases. Besides being a simple, inexpensive and routinely measured parameter, it could help in the stratification of patients according to their risk in clinical practice.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.144 n.5 20162016-05-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872016000500012es10.4067/S0034-98872016000500012
institution Scielo Chile
collection Scielo Chile
language Spanish / Castilian
topic Biomarkers
Cardiovascular Diseases
Erythrocytes
Prognosis
spellingShingle Biomarkers
Cardiovascular Diseases
Erythrocytes
Prognosis
Alcaíno,Hernán
Pozo,José
Pavez,Mario
Toledo,Humberto
Ancho de distribución eritrocitaria como potencial biomarcador clínico en enfermedades cardiovasculares
description Red cell distribution width (RDW) is a measurement of the variation in size, as well as an index of heterogeneity of erythrocytes, which is used in combination with other hematologic parameters as an aid to the differential diagnosis of hypochromic anemia. RDW could also serve as a biomarker in the diagnosis and prognosis patients with cardiovascular diseases. However, it is unclear whether the increased heterogeneity is the cause or consequence of other pathophysiological conditions such as renal failure, malnutrition, inflammation and oxidative stress, which among other conditions are actively involved in the genesis and progression of cardiovascular diseases. The aim of this review is to show and discuss recent evidence about the role of RDW measurement as an aid in the diagnosis and prognosis of patients with such diseases. Besides being a simple, inexpensive and routinely measured parameter, it could help in the stratification of patients according to their risk in clinical practice.
author Alcaíno,Hernán
Pozo,José
Pavez,Mario
Toledo,Humberto
author_facet Alcaíno,Hernán
Pozo,José
Pavez,Mario
Toledo,Humberto
author_sort Alcaíno,Hernán
title Ancho de distribución eritrocitaria como potencial biomarcador clínico en enfermedades cardiovasculares
title_short Ancho de distribución eritrocitaria como potencial biomarcador clínico en enfermedades cardiovasculares
title_full Ancho de distribución eritrocitaria como potencial biomarcador clínico en enfermedades cardiovasculares
title_fullStr Ancho de distribución eritrocitaria como potencial biomarcador clínico en enfermedades cardiovasculares
title_full_unstemmed Ancho de distribución eritrocitaria como potencial biomarcador clínico en enfermedades cardiovasculares
title_sort ancho de distribución eritrocitaria como potencial biomarcador clínico en enfermedades cardiovasculares
publisher Sociedad Médica de Santiago
publishDate 2016
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872016000500012
work_keys_str_mv AT alcainohernan anchodedistribucioneritrocitariacomopotencialbiomarcadorclinicoenenfermedadescardiovasculares
AT pozojose anchodedistribucioneritrocitariacomopotencialbiomarcadorclinicoenenfermedadescardiovasculares
AT pavezmario anchodedistribucioneritrocitariacomopotencialbiomarcadorclinicoenenfermedadescardiovasculares
AT toledohumberto anchodedistribucioneritrocitariacomopotencialbiomarcadorclinicoenenfermedadescardiovasculares
_version_ 1718436883729481728